SlideShare a Scribd company logo
G E N E
T H E R A P Y
GROUP 4
ROXAS, Champagne
SABADO, Althea Maurice
SAGUN, Juswil
SILVA, Lyka
SUDARIA,Kathleen
TACLIAD, Cyda Jesie
TRAJANO, Kazandra Nicole
2
What is gene therapy?
3
⦁ Gene therapy is an experimental technique that uses
genes to treat or prevent disease.
⦁ Gene therapy is when DNA is introduced into a
patient to treat a genetic disease. The new DNA
usually contains a functioning gene to correct the
effects of a disease-causing mutation.
⦁ Gene therapy uses sections of DNA (usually genes)
to treat or prevent disease.
⦁ The DNA is carefully selected to correct the effect of
a mutated gene that is causing disease.
4
There are two
different types of
gene therapy
depending on
which types of cells
are treated:
“ A. SOMATIC GENE
THERAPY:
transfer of a section of DNA to
any cell of the body that doesn’t
produce sperm or eggs. Effects
of gene therapy will not be
passed onto the patient’s
children.
5
6
A. SOMATIC GENE THERAPY
“ B. GERMLINE GENE
THERAPY:
transfer of a section of DNA to
cells that produce eggs or
sperm. Effects of gene therapy
will be passed onto the patient’s
children and subsequent
generations.
7
8
B. GERMLINE GENE THERAPY
9
G E N E
T H E R A P Y
T E C H N I Q U E S
G E N E
A U G M E N T A T I O N
T H E R A P Y
1
⦁ This is used to treat diseases caused by a
mutation that stops a gene from producing a
functioning product, such as a protein.
⦁ This therapy adds DNA containing a functional
version of the lost gene back into the cell.
⦁ The new gene produces a functioning product
at sufficient levels to replace the protein that
was originally missing.
11
⦁ This is only successful if the effects of the
disease are reversible or have not resulted in
lasting damage to the body.
⦁ For example, this can be used to treat loss of
function disorders such as cystic fibrosis by
introducing a functional copy of the gene to
correct the disease.
12
13
G E N E
I N H I B I T I O N
T H E R A P Y
2
⦁ Suitable for the treatment of infectious diseases,
cancer and inherited disease caused by
inappropriate gene activity.
⦁ The aim is to introduce a gene whose product
either:
⦁ inhibits the expression of another gene
⦁ interferes with the activity of the product of
another gene.
15
⦁ The basis of this therapy is to eliminate the activity of
a gene that encourages the growth of disease-related
cells.
⦁ For example, cancer is sometimes the result of the
over-activation of an oncogene (gene which
stimulates cell growth). So, by eliminating the activity
of that oncogene through gene inhibition therapy, it is
possible to prevent further cell growth and stop the
cancer in its tracks.
16
17
⦁ Suitable for diseases such as cancer that
can be treated by destroying certain
groups of cells.
⦁ The aim is to insert DNA into a diseased
cell that causes that cell to die.
18
KILLING OF SPECIFIC CELLS
⦁ This can be achieved in one of two ways:
⦁ the inserted DNA contains a “suicide” gene that produces
a highly toxic product which kills the diseased cell
⦁ the inserted DNA causes expression of a protein that
marks the cells so that the diseased cells are attacked by
the body’s natural immune system.
⦁ It is essential with this method that the inserted DNA is targeted
appropriately to avoid the death of cells that are functioning
normally.
19
KILLING OF SPECIFIC CELLS
21
How is DNA
transfer
done?
⦁ A section of DNA/gene containing instructions for
making a useful protein is packaged within a vector,
usually a virus, bacterium or plasmid.
⦁ The vector acts as a vehicle to carry the new DNA into
the cells of a patient with a genetic disease.
⦁ Once inside the cells of the patient, the DNA/gene is
expressed by the cell’s normal machinery leading to
production of the therapeutic protein and treatment
of the patient’s disease.
22
DNA
transfer
Challenges
of gene
therapy
Delivering the gene to the right place
and switching it on:
• it is crucial that the new gene reaches
the right cell
• delivering a gene into the wrong cell
would be inefficient and could also
cause health problems for the patient
• even once the right cell has been
targeted the gene has to be turned on
• cells sometimes obstruct this process
by shutting down genes that are
showing unusual activity.
Challenges
of gene
therapy
Avoiding the immune response:
• The role of the immune system is to fight off
intruders.
• Sometimes new genes introduced by gene
therapy are considered potentially-harmful
intruders.
• This can spark an immune response in the
patient, that could be harmful to them.
• Scientists therefore have the challenge of
finding a way to deliver genes without the
immune system ‘noticing’.
• This is usually by using vectors that are less
likely to trigger an immune response.
Challenges
of gene
therapy
Making sure the new gene doesn’t disrupt the
function of other genes:
• Ideally, a new gene introduced by gene
therapy will integrate itself into the genome
of the patient and continue working for the
rest of their lives.
• There is a risk that the new gene will insert
itself into the path of another gene,
disrupting its activity.
• This could have damaging effects, for
example, if it interferes with an important
gene involved in regulating cell division, it
could result in cancer.
The cost of
gene therapy:
• Many genetic disorders that can be
targeted with gene therapy are
extremely rare.
• Gene therapy therefore often
requires an individual, case-by-case
approach. This may be effective, but
may also be very expensive.
28
Thanks!

More Related Content

What's hot

PPT Monoclonal antibodies in Endocrinology
PPT Monoclonal antibodies in Endocrinology PPT Monoclonal antibodies in Endocrinology
PPT Monoclonal antibodies in Endocrinology
Shinjan Patra
 
Erik Boot - Studying Psychosis in 22q11 Deletion Syndrome
Erik Boot - Studying Psychosis in 22q11 Deletion SyndromeErik Boot - Studying Psychosis in 22q11 Deletion Syndrome
Erik Boot - Studying Psychosis in 22q11 Deletion Syndrome
wef
 
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
DrPravinPatelNevada
 
Asco 2016 GU Review
Asco 2016 GU ReviewAsco 2016 GU Review
Asco 2016 GU Review
OSUCCC - James
 
Gene therapy
Gene therapyGene therapy
Gene therapy
Vikas Dagar
 
WHMS PGx Presentation
WHMS PGx PresentationWHMS PGx Presentation
WHMS PGx Presentation
Orion Cuffe
 
Ppt ACC follow up
Ppt ACC follow upPpt ACC follow up
Ppt ACC follow up
Shinjan Patra
 
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
Pranav Sopory
 
Car t cell basics cell therapy working group 11.21.19
Car t cell basics  cell therapy working group 11.21.19Car t cell basics  cell therapy working group 11.21.19
Car t cell basics cell therapy working group 11.21.19
Miomir Knežević
 
Sipuleucel T Presentation Anna Begelfer Ostrovski
Sipuleucel T Presentation Anna Begelfer OstrovskiSipuleucel T Presentation Anna Begelfer Ostrovski
Sipuleucel T Presentation Anna Begelfer Ostrovskibegelfer
 
Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
Michel Dumontier
 
Lenalidomide and Stem Cell Collection in Patients with Myeloma 5.22.08
Lenalidomide and Stem Cell Collection in Patients with Myeloma 5.22.08Lenalidomide and Stem Cell Collection in Patients with Myeloma 5.22.08
Lenalidomide and Stem Cell Collection in Patients with Myeloma 5.22.08
Leonard Davis Institute of Health Economics
 
Personalized medicine ppt
Personalized medicine pptPersonalized medicine ppt
Personalized medicine ppt
Irene Daniel
 
INNOVATIONS: ARRIVAL OF GENE THERAPY
INNOVATIONS: ARRIVAL OF GENE THERAPYINNOVATIONS: ARRIVAL OF GENE THERAPY
INNOVATIONS: ARRIVAL OF GENE THERAPY
shahvatsal95
 
Tauopathy and its therapeutic targets
Tauopathy and its therapeutic targetsTauopathy and its therapeutic targets
Tauopathy and its therapeutic targets
Pranav Sopory
 
Personalised medicines 1 (1)
Personalised medicines 1 (1)Personalised medicines 1 (1)
Personalised medicines 1 (1)
JyotiMhoprekar
 
EngenuitySC's March Science Cafe with Dr. Woster
EngenuitySC's March Science Cafe with Dr. WosterEngenuitySC's March Science Cafe with Dr. Woster
EngenuitySC's March Science Cafe with Dr. Woster
EngenuitySC
 
RRC 2011 : Pharmacogénétique et médecine personnalisée du diabète
RRC 2011 : Pharmacogénétique et médecine personnalisée du diabèteRRC 2011 : Pharmacogénétique et médecine personnalisée du diabète
RRC 2011 : Pharmacogénétique et médecine personnalisée du diabète
EuroHealthNet
 

What's hot (20)

PPT Monoclonal antibodies in Endocrinology
PPT Monoclonal antibodies in Endocrinology PPT Monoclonal antibodies in Endocrinology
PPT Monoclonal antibodies in Endocrinology
 
Erik Boot - Studying Psychosis in 22q11 Deletion Syndrome
Erik Boot - Studying Psychosis in 22q11 Deletion SyndromeErik Boot - Studying Psychosis in 22q11 Deletion Syndrome
Erik Boot - Studying Psychosis in 22q11 Deletion Syndrome
 
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
 
BDSRA 2015 CLN3 Kielian
BDSRA 2015 CLN3 KielianBDSRA 2015 CLN3 Kielian
BDSRA 2015 CLN3 Kielian
 
Asco 2016 GU Review
Asco 2016 GU ReviewAsco 2016 GU Review
Asco 2016 GU Review
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
WHMS PGx Presentation
WHMS PGx PresentationWHMS PGx Presentation
WHMS PGx Presentation
 
Ppt ACC follow up
Ppt ACC follow upPpt ACC follow up
Ppt ACC follow up
 
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
 
Car t cell basics cell therapy working group 11.21.19
Car t cell basics  cell therapy working group 11.21.19Car t cell basics  cell therapy working group 11.21.19
Car t cell basics cell therapy working group 11.21.19
 
Sipuleucel T Presentation Anna Begelfer Ostrovski
Sipuleucel T Presentation Anna Begelfer OstrovskiSipuleucel T Presentation Anna Begelfer Ostrovski
Sipuleucel T Presentation Anna Begelfer Ostrovski
 
Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
 
Lenalidomide and Stem Cell Collection in Patients with Myeloma 5.22.08
Lenalidomide and Stem Cell Collection in Patients with Myeloma 5.22.08Lenalidomide and Stem Cell Collection in Patients with Myeloma 5.22.08
Lenalidomide and Stem Cell Collection in Patients with Myeloma 5.22.08
 
Personalized medicine ppt
Personalized medicine pptPersonalized medicine ppt
Personalized medicine ppt
 
INNOVATIONS: ARRIVAL OF GENE THERAPY
INNOVATIONS: ARRIVAL OF GENE THERAPYINNOVATIONS: ARRIVAL OF GENE THERAPY
INNOVATIONS: ARRIVAL OF GENE THERAPY
 
prognostic factor glioma
prognostic factor gliomaprognostic factor glioma
prognostic factor glioma
 
Tauopathy and its therapeutic targets
Tauopathy and its therapeutic targetsTauopathy and its therapeutic targets
Tauopathy and its therapeutic targets
 
Personalised medicines 1 (1)
Personalised medicines 1 (1)Personalised medicines 1 (1)
Personalised medicines 1 (1)
 
EngenuitySC's March Science Cafe with Dr. Woster
EngenuitySC's March Science Cafe with Dr. WosterEngenuitySC's March Science Cafe with Dr. Woster
EngenuitySC's March Science Cafe with Dr. Woster
 
RRC 2011 : Pharmacogénétique et médecine personnalisée du diabète
RRC 2011 : Pharmacogénétique et médecine personnalisée du diabèteRRC 2011 : Pharmacogénétique et médecine personnalisée du diabète
RRC 2011 : Pharmacogénétique et médecine personnalisée du diabète
 

Similar to Gene Therapy

Gene therapy
Gene therapyGene therapy
Gene therapy
Tathagat Sah
 
Gene therapy
Gene therapyGene therapy
Gene therapy
Sara Qasim
 
GENE THERAPY : introduction, advancements and applications
GENE THERAPY : introduction, advancements and applicationsGENE THERAPY : introduction, advancements and applications
GENE THERAPY : introduction, advancements and applications
hritika508
 
Strategies of gene therapy
Strategies of gene therapyStrategies of gene therapy
Strategies of gene therapy
Bahauddin Zakariya University lahore
 
Gene therapy
Gene therapyGene therapy
Gene therapy
RAM PRAKASH
 
Genetic as medicine
Genetic as medicineGenetic as medicine
Genetic as medicine
vlmawia
 
Study on gene therapy
Study on gene therapyStudy on gene therapy
Study on gene therapy
Zoha Hussain
 
Gene therapy presentation
Gene therapy presentationGene therapy presentation
Gene therapy presentation
Smart Cell
 
Gene therapy
Gene therapyGene therapy
Gene therapy
zeemalshah
 
Gene therapy
Gene therapyGene therapy
Gene therapy
Samvartika Majumdar
 
Gene therapy
Gene therapyGene therapy
Gene therapy
SmritiBhardwaj13
 
THE TREATMENT OF GENETIC DISEASE.pptx
THE TREATMENT OF GENETIC DISEASE.pptxTHE TREATMENT OF GENETIC DISEASE.pptx
THE TREATMENT OF GENETIC DISEASE.pptx
drRiyan1
 
Gene therapy
Gene therapyGene therapy
Gene therapy
Hassan Rajab
 
Gene Therapy
Gene TherapyGene Therapy
Gene Therapy
Nisar Ali
 
GENE THERAPY.docx
GENE THERAPY.docxGENE THERAPY.docx
GENE THERAPY.docx
VarshaSanjeev
 
Gene Therapy
Gene TherapyGene Therapy
Gene Therapy
Shrikesh Kumar Rai
 
Gene therapy dr. asm
Gene therapy dr. asmGene therapy dr. asm
Genetic Engineering
Genetic Engineering Genetic Engineering
Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)
Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)
Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)
Canadian Organization for Rare Disorders
 
Nucleic acid based therapeutic delivery system
Nucleic acid based therapeutic delivery systemNucleic acid based therapeutic delivery system
Nucleic acid based therapeutic delivery system
Genesis Institute of Pharmacy, Radhanagari.
 

Similar to Gene Therapy (20)

Gene therapy
Gene therapyGene therapy
Gene therapy
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
GENE THERAPY : introduction, advancements and applications
GENE THERAPY : introduction, advancements and applicationsGENE THERAPY : introduction, advancements and applications
GENE THERAPY : introduction, advancements and applications
 
Strategies of gene therapy
Strategies of gene therapyStrategies of gene therapy
Strategies of gene therapy
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Genetic as medicine
Genetic as medicineGenetic as medicine
Genetic as medicine
 
Study on gene therapy
Study on gene therapyStudy on gene therapy
Study on gene therapy
 
Gene therapy presentation
Gene therapy presentationGene therapy presentation
Gene therapy presentation
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
THE TREATMENT OF GENETIC DISEASE.pptx
THE TREATMENT OF GENETIC DISEASE.pptxTHE TREATMENT OF GENETIC DISEASE.pptx
THE TREATMENT OF GENETIC DISEASE.pptx
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Gene Therapy
Gene TherapyGene Therapy
Gene Therapy
 
GENE THERAPY.docx
GENE THERAPY.docxGENE THERAPY.docx
GENE THERAPY.docx
 
Gene Therapy
Gene TherapyGene Therapy
Gene Therapy
 
Gene therapy dr. asm
Gene therapy dr. asmGene therapy dr. asm
Gene therapy dr. asm
 
Genetic Engineering
Genetic Engineering Genetic Engineering
Genetic Engineering
 
Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)
Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)
Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)
 
Nucleic acid based therapeutic delivery system
Nucleic acid based therapeutic delivery systemNucleic acid based therapeutic delivery system
Nucleic acid based therapeutic delivery system
 

Recently uploaded

Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
AADYARAJPANDEY1
 
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
ssuserbfdca9
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
AADYARAJPANDEY1
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
IqrimaNabilatulhusni
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
University of Maribor
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
DiyaBiswas10
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
sonaliswain16
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
ossaicprecious19
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
NathanBaughman3
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
muralinath2
 

Recently uploaded (20)

Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
 
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
 

Gene Therapy

  • 1. G E N E T H E R A P Y GROUP 4 ROXAS, Champagne SABADO, Althea Maurice SAGUN, Juswil SILVA, Lyka SUDARIA,Kathleen TACLIAD, Cyda Jesie TRAJANO, Kazandra Nicole
  • 2. 2 What is gene therapy?
  • 3. 3 ⦁ Gene therapy is an experimental technique that uses genes to treat or prevent disease. ⦁ Gene therapy is when DNA is introduced into a patient to treat a genetic disease. The new DNA usually contains a functioning gene to correct the effects of a disease-causing mutation. ⦁ Gene therapy uses sections of DNA (usually genes) to treat or prevent disease. ⦁ The DNA is carefully selected to correct the effect of a mutated gene that is causing disease.
  • 4. 4 There are two different types of gene therapy depending on which types of cells are treated:
  • 5. “ A. SOMATIC GENE THERAPY: transfer of a section of DNA to any cell of the body that doesn’t produce sperm or eggs. Effects of gene therapy will not be passed onto the patient’s children. 5
  • 7. “ B. GERMLINE GENE THERAPY: transfer of a section of DNA to cells that produce eggs or sperm. Effects of gene therapy will be passed onto the patient’s children and subsequent generations. 7
  • 9. 9 G E N E T H E R A P Y T E C H N I Q U E S
  • 10. G E N E A U G M E N T A T I O N T H E R A P Y 1
  • 11. ⦁ This is used to treat diseases caused by a mutation that stops a gene from producing a functioning product, such as a protein. ⦁ This therapy adds DNA containing a functional version of the lost gene back into the cell. ⦁ The new gene produces a functioning product at sufficient levels to replace the protein that was originally missing. 11
  • 12. ⦁ This is only successful if the effects of the disease are reversible or have not resulted in lasting damage to the body. ⦁ For example, this can be used to treat loss of function disorders such as cystic fibrosis by introducing a functional copy of the gene to correct the disease. 12
  • 13. 13
  • 14. G E N E I N H I B I T I O N T H E R A P Y 2
  • 15. ⦁ Suitable for the treatment of infectious diseases, cancer and inherited disease caused by inappropriate gene activity. ⦁ The aim is to introduce a gene whose product either: ⦁ inhibits the expression of another gene ⦁ interferes with the activity of the product of another gene. 15
  • 16. ⦁ The basis of this therapy is to eliminate the activity of a gene that encourages the growth of disease-related cells. ⦁ For example, cancer is sometimes the result of the over-activation of an oncogene (gene which stimulates cell growth). So, by eliminating the activity of that oncogene through gene inhibition therapy, it is possible to prevent further cell growth and stop the cancer in its tracks. 16
  • 17. 17
  • 18. ⦁ Suitable for diseases such as cancer that can be treated by destroying certain groups of cells. ⦁ The aim is to insert DNA into a diseased cell that causes that cell to die. 18 KILLING OF SPECIFIC CELLS
  • 19. ⦁ This can be achieved in one of two ways: ⦁ the inserted DNA contains a “suicide” gene that produces a highly toxic product which kills the diseased cell ⦁ the inserted DNA causes expression of a protein that marks the cells so that the diseased cells are attacked by the body’s natural immune system. ⦁ It is essential with this method that the inserted DNA is targeted appropriately to avoid the death of cells that are functioning normally. 19 KILLING OF SPECIFIC CELLS
  • 20.
  • 22. ⦁ A section of DNA/gene containing instructions for making a useful protein is packaged within a vector, usually a virus, bacterium or plasmid. ⦁ The vector acts as a vehicle to carry the new DNA into the cells of a patient with a genetic disease. ⦁ Once inside the cells of the patient, the DNA/gene is expressed by the cell’s normal machinery leading to production of the therapeutic protein and treatment of the patient’s disease. 22
  • 24. Challenges of gene therapy Delivering the gene to the right place and switching it on: • it is crucial that the new gene reaches the right cell • delivering a gene into the wrong cell would be inefficient and could also cause health problems for the patient • even once the right cell has been targeted the gene has to be turned on • cells sometimes obstruct this process by shutting down genes that are showing unusual activity.
  • 25. Challenges of gene therapy Avoiding the immune response: • The role of the immune system is to fight off intruders. • Sometimes new genes introduced by gene therapy are considered potentially-harmful intruders. • This can spark an immune response in the patient, that could be harmful to them. • Scientists therefore have the challenge of finding a way to deliver genes without the immune system ‘noticing’. • This is usually by using vectors that are less likely to trigger an immune response.
  • 26. Challenges of gene therapy Making sure the new gene doesn’t disrupt the function of other genes: • Ideally, a new gene introduced by gene therapy will integrate itself into the genome of the patient and continue working for the rest of their lives. • There is a risk that the new gene will insert itself into the path of another gene, disrupting its activity. • This could have damaging effects, for example, if it interferes with an important gene involved in regulating cell division, it could result in cancer.
  • 27. The cost of gene therapy: • Many genetic disorders that can be targeted with gene therapy are extremely rare. • Gene therapy therefore often requires an individual, case-by-case approach. This may be effective, but may also be very expensive.